NAMS - NewAmsterdam Pharma Company N.V.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.00
DETAILS
HIGH:
$55.00
LOW:
$37.00
MEDIAN:
$46.00
CONSENSUS:
$46.00
UPSIDE:
29.80%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 4,203,567 | $134.6M | 0.4% | -- | UNCHANGED |
| Druckenmiller | 3,070,146 | $98.3M | 2.9% | -- | UNCHANGED |
| Wood | 18,200 | $582,582 | 0.0% | +18,200 | NEW |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-03-11 | LANGE LOUIS G | director | SELL | 44,173 | $30.41 | $1.3M |
| 2026-03-11 | LANGE LOUIS G | director | SELL | 446 | $31.23 | $14K |
| 2026-03-06 | LANGE LOUIS G | director | SELL | 28,186 | $29.41 | $829K |
| 2026-03-09 | LANGE LOUIS G | director | X-InTheMoney | 44,619 | $11.50 | $513K |
| 2026-03-05 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | M-Exempt | 104,467 | -- | -- |
| 2026-03-09 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | M-Exempt | 101,409 | -- | -- |
| 2026-03-06 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | SELL | 94,124 | $30.32 | $2.9M |
| 2026-03-06 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | M-Exempt | 94,124 | -- | -- |
| 2026-03-05 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | SELL | 104,467 | $30.30 | $3.2M |
| 2026-03-09 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | SELL | 101,409 | $30.29 | $3.1M |
| 2026-03-02 | Davidson Michael H. | director, officer: Chief Executive Officer | M-Exempt | 443,707 | -- | -- |
| 2026-03-02 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 443,707 | $33.25 | $14.8M |
| 2026-02-26 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 165,408 | $33.63 | $5.6M |
| 2026-02-25 | Davidson Michael H. | director, officer: Chief Executive Officer | M-Exempt | 58,253 | -- | -- |
| 2026-02-24 | Davidson Michael H. | director, officer: Chief Executive Officer | M-Exempt | 64,708 | -- | -- |
| 2026-02-25 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 46,517 | $35.11 | $1.6M |
| 2026-02-24 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 61,547 | $36.13 | $2.2M |
| 2026-02-25 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 10,436 | $35.96 | $375K |
| 2026-02-24 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 3,161 | $36.46 | $115K |
| 2026-02-26 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 17,924 | $34.44 | $617K |
| 2026-02-25 | Davidson Michael H. | director, officer: Chief Executive Officer | SELL | 1,300 | $36.68 | $48K |
| 2026-02-26 | Davidson Michael H. | director, officer: Chief Executive Officer | M-Exempt | 183,332 | -- | -- |
| 2026-02-20 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | SELL | 14,692 | $35.00 | $514K |
| 2026-02-20 | Kastelein Johannes Jacob Pieter | director, officer: Chief Scientific Officer | SELL | 30,789 | $35.46 | $1.1M |
| 2026-01-28 | Kooij Louise Frederika | officer: Chief Accounting Officer | M-Exempt | 32,612 | $10.90 | $355K |